The CAVEI responds to the request of the National Immunization Program (PNI) of the Ministry of Health (MINSAL) received on July 4, 2023 to evaluate the incorporation vaccination against respiratory syncytial virus in the PNI. In this document, the CAVEI analyzes the available evidence on efficacy, safety and immunogenicity of the vaccines, background on cost effectiveness and international recommendations.

  • Recommendation
  • Americas
  • Chile
  • Older adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)